Global Health and Life Sciences by US-China Series published on 2020-02-03T17:55:04Z Reevaluating the US-China relationship means understanding the growing role of China in health, development and other essential global goals. Using low-cost, rapid commercialization capability to scale up affordable solutions is an effective model for China, and its own technology is becoming increasingly sophisticated. What does this new landscape mean for US institutions and what opportunities are there to collaborate to improve human conditions around the world? SPEAKER 1: Steve Davis, PATH SPEAKER 2: Kathleen Walsh, Gates Foundation SPEAKER 3: Benjamin Shobert, Microsoft/NBR SPEAKER 4: Jennifer Bouey, RAND Corporation MODERATOR: Kristi Heim, BGI Group/WSCRC Genre Business
